207 related articles for article (PubMed ID: 22206075)
1. Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines.
Glogau R; Blitzer A; Brandt F; Kane M; Monheit GD; Waugh JM
J Drugs Dermatol; 2012 Jan; 11(1):38-45. PubMed ID: 22206075
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.
Brandt F; O'Connell C; Cazzaniga A; Waugh JM
Dermatol Surg; 2010 Dec; 36 Suppl 4():2111-8. PubMed ID: 21134043
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.
Brandt F
Dermatol Surg; 2011 Jul; 37(7):1060. PubMed ID: 21711409
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
Ascher B; Rzany BJ; Grover R
Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.
Hanke CW; Narins RS; Brandt F; Cohen JL; Donofrio LM; Downie J; Heinz M; Harrington L; McDaniel DH; Nestor M; Schlessinger J; Schlöbe A; Taub A; Weiss RA
Dermatol Surg; 2013 Jun; 39(6):891-9. PubMed ID: 23506308
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
Ho MC; Hsu WC; Hsieh YT
JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
8. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study.
Won CH; Lee HM; Lee WS; Kang H; Kim BJ; Kim WS; Lee JH; Lee DH; Huh CH
Dermatol Surg; 2013 Jan; 39(1 Pt 2):171-8. PubMed ID: 23301821
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
Carruthers JD; Lowe NJ; Menter MA; Gibson J; Eadie N;
Plast Reconstr Surg; 2003 Sep; 112(4):1089-98. PubMed ID: 12973229
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose.
Monheit G; Carruthers A; Brandt F; Rand R
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S51-9. PubMed ID: 17241415
[TBL] [Abstract][Full Text] [Related]
13. Cosmetic applications of botulinum toxin in oculofacial region.
Sarić D
Acta Clin Croat; 2010 Dec; 49(4):525-8. PubMed ID: 21830467
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a new clinically-meaningful rating scale for measuring lateral canthal line severity.
Kane MA; Blitzer A; Brandt FS; Glogau RG; Monheit GD; Narins RS; Paty JA; Waugh JM
Aesthet Surg J; 2012 Mar; 32(3):275-85. PubMed ID: 22395318
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
[TBL] [Abstract][Full Text] [Related]
16. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC
J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
[TBL] [Abstract][Full Text] [Related]
17. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
Phillips TJ; Symons J; Menon S;
J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
Carruthers A; Carruthers J; Coleman WP; Donofrio L; Flynn T; Gold M; Heinz M; Harrington L; Jones D; McDaniel D; Rohrer T; Schlöbe A; Solish N; Weiss RA
Dermatol Surg; 2013 Apr; 39(4):551-8. PubMed ID: 23379292
[TBL] [Abstract][Full Text] [Related]
19. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
Fabi SG; Sundaram H; Guiha I; Goldman MP
J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of and patient satisfaction with injectable hyaluronic acid with 0.3% lidocaine hydrochloride for the treatment of superficial perioral lines or superficial lateral canthal lines.
Fabi SG; Champagne JP; Nettar KD; Maas CS; Goldman MP
Dermatol Surg; 2013 Nov; 39(11):1613-20. PubMed ID: 24118510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
